New Drug Applications Merck Announces FDA Acceptance of Biologics License Application for Clesrovimab, an Investigational Long-Acting Monoclonal Antibody Designed to Protect Infants from RSV Disease During their First RSV Season 1 month ago
Uncategorized Increased Odds of Leaving ED Before Medically Advised Tied to COVID-19 Pandemic 1 month ago
New Drug Applications U.S. Food and Drug Administration Issues Complete Response Letter for the Glepaglutide New Drug Application for the Treatment of Short Bowel Syndrome 1 month ago
New Drug Applications PTC Therapeutics Announces Vatiquinone NDA Submission to FDA for the Treatment of Children and Adults Living with Friedreich Ataxia 1 month ago
New Drug Applications Lexicon Announces Receipt of Complete Response Letter for Zynquista (sotagliflozin) 1 month ago
New Drug Applications Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia 1 month ago